SYGNIS Anounces Change In Guarantee For Spanish Government Soft Loans
Share loan from Dr. Heikki Lanckriet guarantees government soft loans
Madrid, Spain and Heidelberg, Germany, March 22, 2017 – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that Dr. Heikki Lanckriet, Co-CEO and CSO of SYGNIS, will guarantee soft loans from the Spanish government with 500,000 of his SYGNIS shares. The guarantee secures the EUR 1.9 million non-dilutive R&D funding SYGNIS received from the Spanish Ministry of Economy and Competitiveness (MINECO) in 2016.
Pilar de la Huerta, Co-CEO and CBDO, commented: “We appreciate the strong commitment of Heikki Lanckriet and highly value his support.”
For further information, please contact:
SYGNIS AG
Dr. Heikki Lanckriet
Co-CEO/CSO
Phone : +44 1223 873 364
Email : heikki.lanckriet@sygnis.com
Pilar de la Huerta
Co-CEO/CBDO
Phone: +34 91 192 36 50
Email: pdelahuerta@sygnis.com
MC Services AG
Raimund Gabriel
Managing Partner
Phone: +49 89 210228 0
Email: raimund.gabriel@mc-services.eu
About SYGNIS AG: www.sygnis.com
SYGNIS AG is specialized in the development and the commercialization of proprietary technologies and offers a wide range of different commercial products addressing key challenges in molecular biology. With the acquisition of Expedeon Holdings, Ltd. based in Cambridge, UK, SYGNIS has added a complementary proteomic product portfolio. Resulting from this significant expansion, SYGNIS’ product portfolio now covers the entire workflow of molecular biology. The products are sold through a direct sales force and several distribution partners in Europe, the US and Asia. SYGNIS AG has offices in Germany, Spain and the UK, production sites in the UK and the US as well as sales offices in Asia. The company is listed on the German Stock Exchange in Frankfurt in the Prime Standard segment (Ticker: LIO1; ISIN: DE000A1RFM03).
Madrid, Spain and Heidelberg, Germany, March 22, 2017 – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that Dr. Heikki Lanckriet, Co-CEO and CSO of SYGNIS, will guarantee soft loans from the Spanish government with 500,000 of his SYGNIS shares. The guarantee secures the EUR 1.9 million non-dilutive R&D funding SYGNIS received from the Spanish Ministry of Economy and Competitiveness (MINECO) in 2016.
Pilar de la Huerta, Co-CEO and CBDO, commented: “We appreciate the strong commitment of Heikki Lanckriet and highly value his support.”
For further information, please contact:
SYGNIS AG
Dr. Heikki Lanckriet
Co-CEO/CSO
Phone : +44 1223 873 364
Email : heikki.lanckriet@sygnis.com
Pilar de la Huerta
Co-CEO/CBDO
Phone: +34 91 192 36 50
Email: pdelahuerta@sygnis.com
MC Services AG
Raimund Gabriel
Managing Partner
Phone: +49 89 210228 0
Email: raimund.gabriel@mc-services.eu
About SYGNIS AG: www.sygnis.com
SYGNIS AG is specialized in the development and the commercialization of proprietary technologies and offers a wide range of different commercial products addressing key challenges in molecular biology. With the acquisition of Expedeon Holdings, Ltd. based in Cambridge, UK, SYGNIS has added a complementary proteomic product portfolio. Resulting from this significant expansion, SYGNIS’ product portfolio now covers the entire workflow of molecular biology. The products are sold through a direct sales force and several distribution partners in Europe, the US and Asia. SYGNIS AG has offices in Germany, Spain and the UK, production sites in the UK and the US as well as sales offices in Asia. The company is listed on the German Stock Exchange in Frankfurt in the Prime Standard segment (Ticker: LIO1; ISIN: DE000A1RFM03).